Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Benamran

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 11, 2025
Leveraging multi-organ models for drug combination therapy safetyValentin Mieville, Jakub Gubala, Seungsu Han, et al.
Pharmaceutics|October 29, 2025
Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell CarcinomaValentin Mieville, Jakub Gubala, Mathis Fiault, et al.
World Journal of Urology|April 22, 2024
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation studyRomain Diamand, Jean-Baptiste Roche, Vito Lacetera, et al.
Urologic Oncology|October 9, 2020
Postoperative assessment of nosocomial transmission of COVID-19 after robotic surgical procedures during the pandemicThomas Tabourin, Judith Sarfati, Ugo Pinar, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2023
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patientsMichael Baboudjian, Alessandro Uleri, Jean-Baptiste Beauval, et al.
European Urology Open Science|January 5, 2023
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European StudyOlivier Windisch, Daniel Benamran, Charles Dariane, et al.
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
European Urology|March 17, 2024
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
European Urology Open Science|May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice ExperimentDominik Menges, Michela C Piatti, Aurelius Omlin, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 11, 2025
Leveraging multi-organ models for drug combination therapy safetyValentin Mieville, Jakub Gubala, Seungsu Han, et al.
Pharmaceutics|October 29, 2025
Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell CarcinomaValentin Mieville, Jakub Gubala, Mathis Fiault, et al.
World Journal of Urology|April 22, 2024
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation studyRomain Diamand, Jean-Baptiste Roche, Vito Lacetera, et al.
Urologic Oncology|October 9, 2020
Postoperative assessment of nosocomial transmission of COVID-19 after robotic surgical procedures during the pandemicThomas Tabourin, Judith Sarfati, Ugo Pinar, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2023
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patientsMichael Baboudjian, Alessandro Uleri, Jean-Baptiste Beauval, et al.
European Urology Open Science|January 5, 2023
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European StudyOlivier Windisch, Daniel Benamran, Charles Dariane, et al.
Urologic Oncology|May 29, 2026
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomesNorbert De Brek, Arthur Peyrottes, Romain Diamand, et al.
European Urology|March 17, 2024
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
European Urology Open Science|May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice ExperimentDominik Menges, Michela C Piatti, Aurelius Omlin, et al.
Pageof 6